Previous close | 0.4500 |
Open | 0.4400 |
Bid | 0.4200 |
Ask | 0.4700 |
Strike | 2.50 |
Expiry date | 2025-01-17 |
Day's range | 0.4200 - 0.4700 |
Contract range | N/A |
Volume | |
Open interest | 42.31k |
Key Takeaways; Cannabis Sector Ayr Wellness reported solid first quarter results. Cresco Labs reported stagnant sales but an optimistic outlook for 2024. Tilray announced a $250 million equity offering to fund U.S. asset acquisitions amid legalization optimism. Flora Growth is strategizing on cannabis reform to its reverse financial trend. Key Takeaways; Psychedelic Sector Enveric Biosciences […]
Shares of Tilray Brands (TLRY) fell sharply on Friday after filing to offer up to $250 million worth of additional shares. The company says the funds would be used to make acquisitions or other investments, not for general purposes. Tilray says it is positioning itself to be ready for the potential reclassification of marijuana, something President Biden voiced support for on Thursday. Yahoo Finance's Julie Hyman and Josh Lipton recap the latest developments for Tilray. This post was written by Stephanie Mikulich.
NEW YORK and LEAMINGTON, Ontario, May 17, 2024 (GLOBE NEWSWIRE) -- Tilray Brands, Inc. (“Tilray Brands” or the “Company”) (Nasdaq | TSX: TLRY), a leading global lifestyle and consumer packaged goods company inspiring and empowering the worldwide community to live their very best life, announced today that it has filed a prospectus supplement with the U.S. Securities and Exchange Commission (“SEC”), under which it may offer and sell shares of its common stock (“Common Stock”) having an aggregate